Atlas Trials

Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).

Clinical trial NCT05542615 · UNKNOWN

Trial details

NCT number
NCT05542615
Sponsor
University of Guadalajara
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Liver CirrhosisHepatitis C, ChronicEpigenetic Disorder
Start date
2019-08-01
Primary completion
2023-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.